Target intelligence / Profile preview

Leptospira kirschneri serovar Grippotyphosa

Molecular classification
Other, Bacterium, Gram-negative spirochete, Pathogen
01

Overview

Leptospira kirschneri serovar Grippotyphosa is a subspecies and serovar of the spiral-shaped, highly motile Gram-negative bacterium Leptospira kirschneri, a pathogenic species causing leptospirosis in humans and a wide range of animals including rodents, livestock, and wildlife[1][2][4][5]. The Grippotyphosa serovar is part of the Grippotyphosa serogroup, and is notable for its ability to survive in moist environments, but is sensitive to desiccation[1]. It is not a molecular receptor, enzyme, or other medicinal/biological "target" in the classic sense, but an infectious pathogen[2][4]. Transmission typically occurs via contact with urine from infected animals, often mediated through contaminated water or soil[3][4]. Grippotyphosa is an important agent in zoonotic transmission, with reservoir species including field mice and other small wild mammals[3]. Key points: - Not a therapeutic or molecular target; it is a bacterial pathogen. - Causes leptospirosis—an infection sometimes severe in humans and animals. - Can be typed by serological methods (e.g., MAT), as characterized in reference and surveillance studies[2][3][5]. - No direct molecular or drug-targeting relevance; rather, it is the organism responsible for disease where antibiotics are the class of drugs typically used for treatment, but there are no small-molecule drugs that interact with the "target" as would be the case for a receptor or enzyme. The entry presented is not a molecular target/receptor but rather describes an infectious pathogen species/serovar, and thus does not fit typical "target" curation structures[2][4].

Other names
Leptospira kirschneri serogroup Grippotyphosa serovar GrippotyphosaL. kirschneri serovar GrippotyphosaLeptospira kirschneri sv Grippotyphosa
02

Biological functions

InfectionPathogenesisEnvironmental survival
03

Disease associations

Infection (specifically leptospirosis in humans and animals)

Beyond the preview

Go deeper on Leptospira kirschneri serovar Grippotyphosa.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Leptospira kirschneri serovar Grippotyphosa.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call